Therapeutics

Top Story

Emerging best practices improve ocular surface outcomes in glaucoma patients

Emerging best practices improve ocular surface outcomes in glaucoma patients
Primary Care Optometry News, May 2016
Ian Benjamin Gaddie, OD

Ocular surface diseases, such as dry eye disease, can be caused by a number of triggers, including glaucoma treatment, allergies, computer use, the environment, the natural aging process or a combination of factors. By treating ocular surface disease in patients with glaucoma or other eye disease, we can improve patient satisfaction and compliance.

Patients are not always able to articulate the symptoms they are experiencing or they may think that the symptoms are “normal for their age.” Every patient who comes to my practice, regardless of whether they are in the office simply for glasses or a contact lens prescription or for a medically rooted problem such as glaucoma, is given the Standard Patient Evaluation of Eye Dryness (SPEED) survey to evaluate both the frequency and severity of symptoms.

Meeting News Coverage

Study labels laser trabeculoplasty as adjunctive, not alternative, glaucoma treatment

May 12, 2016
SEATTLE – A retrospective analysis has found that 3 months after laser trabeculoplasty, 60% of open-angle glaucoma patients were prescribed at least one topical…
Meeting News Coverage

ARMOR study shows antibiotic resistance levels remain high

May 5, 2016
SEATTLE – Preliminary 2015 data from the Antibiotic Resistance Monitoring in Ocular Microorganism study show that high levels of antibiotic resistance continue…
Meeting News Coverage

Study: Hypochlorous acid eliminates nearly all staph from lower lids

May 3, 2016
SEATTLE – Saline containing 0.01% pure hypochlorous acid was found to reduce Staphylococcus overall from the skin below the eyelid in 99.6% of ocular specimens…

Intranasal stimulator increased tear production in trials

May 26, 2016
Allergan announced that a premarket submission for Oculeve Intranasal Tear Neurostimulator will be submitted to the FDA…
More »

AOA pediatric clinical practice guideline available for public review

May 25, 2016
The American Optometric Association announced its new clinical practice guideline on pediatric eye health is available…
More »
Featured
ARVO

ARVO

In the Journals

Routine eye exams detect new eye conditions in asymptomatic patients

May 27, 2016
Researchers found that more than half of the asymptomatic patients who presented for a routine eye exam had a change in…
More »

Emerging best practices improve ocular surface outcomes in glaucoma patients

Primary Care Optometry News, May 2016
Ian Benjamin Gaddie, OD
Ocular surface diseases, such as dry eye disease, can be caused by a number of triggers, including glaucoma treatment, allergies, computer use, the…

Meeting News Coverage

Study labels laser trabeculoplasty as adjunctive, not alternative, glaucoma treatment

May 12, 2016
SEATTLE – A retrospective analysis has found that 3 months after laser trabeculoplasty, 60% of open-angle glaucoma patients were prescribed at…

Meeting News Coverage

ARMOR study shows antibiotic resistance levels remain high

May 5, 2016
SEATTLE – Preliminary 2015 data from the Antibiotic Resistance Monitoring in Ocular Microorganism study show that high levels of antibiotic…

Meeting News Coverage

Study: Hypochlorous acid eliminates nearly all staph from lower lids

May 3, 2016
SEATTLE – Saline containing 0.01% pure hypochlorous acid was found to reduce Staphylococcus overall from the skin below the eyelid in 99.6% of…

Perspectives on Glaucoma

Trabodenoson significantly reduced IOP in ocular hypertension, POAG

May 2, 2016
Researchers found that twice-daily ocular doses of trabodenoson were well tolerated and decreased IOP in patients with ocular hypertension or primary…

In the Journals

Researchers say tacrolimus may be first-line treatment for patients with VKC

April 29, 2016
Low-dose topical tacrolimus 0.01% solution showed long-term, positive results as a steroid-sparing agent in the management of refractory vernal…

BLOG: Why do they call it Muro 128?

April 28, 2016
“Why do they call it Muro-128?” This one stumped me. As I’ve mentioned before, I write this column each month based on a question…

Meeting News Coverage

Expert panel shares pearls on punctal occlusion

April 25, 2016
NEW YORK – A trio of clinicians recommended the use of punctal occlusion, with specific caveats depending on preoperative use and the type of…

Perspectives on Glaucoma

Fewer medications prior to SLT improve chance of success

April 25, 2016
One-year efficacy of selective laser trabeculoplasty in controlling intraocular pressure was limited in patients with maximal-tolerable medical…

Perspectives on GlaucomaPerspective

Higher glaucoma medication confidence exists when providers educate patients

April 21, 2016
Researchers found higher patient confidence in adhering to glaucoma medication regimens and confidence to administer eye drops correctly when…

More Headlines »
morganatic-roan